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Abstract: The clinical management of bone defects caused by trauma or nonunion fractures 
remains a challenge in orthopedic practice due to the poor integration and biocompatibility 
properties of the scaffold or implant material. In the current work, the osteogenic properties 
of carboxyl-modified single-walled carbon nanotubes (COOH–SWCNTs) were investigated 
in vivo and in vitro. When human preosteoblasts and murine embryonic stem cells were 
cultured on coverslips sprayed with COOH–SWCNTs, accelerated osteogenic differentiation 
was manifested by increased expression of classical bone marker genes and an increase in the 
secretion of osteocalcin, in addition to prior mineralization of the extracellular matrix. These 
results predicated COOH–SWCNTs’ use to further promote osteogenic differentiation in vivo. 
In contrast, both cell lines had difficulties adhering to multi-walled carbon nanotube-based 
scaffolds, as shown by scanning electron microscopy. While a suspension of SWCNTs caused 
cytotoxicity in both cell lines at levels 20 μg/mL, these levels were never achieved by release 
from sprayed SWCNTs, warranting the approach taken. In vivo, human allografts formed by the 
combination of demineralized bone matrix or cartilage particles with SWCNTs were implanted 
into nude rats, and ectopic bone formation was analyzed. Histological analysis of both types 
of implants showed high permeability and pore connectivity of the carbon nanotube-soaked 
implants. Numerous vascularization channels appeared in the formed tissue, additional progenitor 
cells were recruited, and areas of de novo ossification were found 4 weeks post-implantation. 
Induction of the expression of bone-related genes and the presence of secreted osteopontin protein 
were also confirmed by quantitative polymerase chain reaction analysis and immunofluores-
cence, respectively. In summary, these results are in line with prior contributions that highlight 
the suitability of SWCNTs as scaffolds with high bone-inducing capabilities both in vitro and 
in vivo, confirming them as alternatives to current bone-repair therapies.
Keywords: human allografts, demineralized bone matrix, cartilage particles, bone regeneration
Introduction
Current surgical procedures for the treatment of bone defects including those resulting 
from tumor resection, trauma, and abnormal bone growth enjoy only partial success, and 
often lead to multiple surgeries. Among these limitations, patients must face responses 
such as quick degradation of implants, poor osteointegration, and fractures. During the 
past few decades, efforts have been made to mitigate these challenges through the use 
of new metal prostheses and the development of new biocompatible materials, such 
as biodegradable polymers, and collagen- and calcium-based scaffolds.1–4
Nanotechnology offers a wide range of alternatives to design new materials that can 
be applied to regenerative medicine. Examples of these nanomaterials include carbon 
nanotubes (CNTs), an allotrope form of carbon5,6 that shows excellent  properties to be 
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employed in diverse fields.7–9 In addition, CNT’s geometry 
resembles triple collagen fibrils.10,11 An individual single-
walled CNT (SW-CNT) is a thin fiber about 1–5 μm in length 
and 0.5–1.5 nm in diameter, closely mimicking the length and 
diameter of collagen fibrils, making them ideal candidates 
for tissue engineering. Despite of their beneficial geometry, 
the application of CNTs in regenerative medicine has caused 
some controversy; a number of published reports have 
questioned their biocompatibility.12–15 However, more recent 
reports on manufactured CNTs using improved methods, 
which reduces heavy metal componentry, have emphasized 
their utility and are reviewed by Tran et al.16
The application of any type of biomaterial in bone regen-
eration must satisfy three criteria; the biomaterial must be: 
1) osteoconductive, sustaining colonization by precursor 
cells and allowing the formation of new vessels; 2) osteoin-
ductive, stimulating bone cell differentiation of precursors; 
and 3) osteointegrative with host bone tissue. Using these 
three criteria, we and others have shown that high-purity 
CNT preparations sprayed on glass surfaces sustained bone 
cell proliferation as well as electrical activities underlying 
osteoblast secretory functions and matrix mineralization.17–19 
In addition, in closely related bioengineering fields, chemi-
cally modified CNTs alone or in combination with distinct 
composite materials have been applied to facilitate neu-
ronal growth, cartilage, and myocardial tissue differentia-
tion, among other applications.20–32 Furthermore, CNTs in 
 suspension have also been investigated as potential carriers 
for drug delivery, and have been shown to have no effect on 
vital functions of cells.31,32
In the current work, we have evaluated the bone-inducing 
properties of carboxyl (COOH)-modified CNTs by conducting 
in vitro experiments on two models of progenitor cells, human 
fetal osteoblasts (hFOBs) and murine embryonic stem cells 
(mESCs), and we have further investigated bone induction in 
vivo in a rat model. While multi-walled, negatively charged 
CNTs altered the adhesive and proliferative properties of cells, 
single-walled carbon nanotubes (SWCNTs) in suspension had 
a putative cytotoxic impact at concentrations 20 μg/mL. 
However, SWCNTs improved differentiation of both hFOB 
and mESC progenitors into osteoblasts in vitro, as confirmed 
by an increase in messenger ribonucleic acid (mRNA), abun-
dance of bone-lineage genes, an earlier induction of extracel-
lular matrix (ECM) mineralization, and induced secretion 
of osteocalcin (Ocn) protein. In vivo, human allografts of 
demineralized bone matrix (DBM) and cartilage particles 
soaked in SWCNT suspension were implanted into athymic 
rats. Histological analysis of resulting tissue and mRNA levels 
of bone marker genes suggested that the tissue formed upon 
transplantation of SWCNT-soaked DBM was more mature 
than that of SWCNT-soaked cartilage particles. In summary, 
our results highlight the relevance of SWCNT-based scaffolds 
in promoting bone formation in vivo and in vitro.
Materials and methods
cNT preparation
Aqueous solutions of carboxyl-modified single- and multi- 
walled CNTs, (COOH–SWCNTs and COOH–MWCNTs, 
respectively; NanoLab Inc., Waltham, MA, USA) were 
sprayed onto glass coverslips (30 mm diameter). Briefly, 
100 μg/mL of sonicated CNT suspension was sprayed onto 
preheated (160°C) glass coverslips, allowed to air-dry, and 
then irradiated with ultraviolet light prior to use in cell culture. 
CNT features are described in Table 1.
cell culture
hFOBs (line 1.19) and mESCs (line D3) were obtained 
from ATCC (American Type Culture Collection, Rockville, 
MD, USA). hFOB 1.19 cells were cultured as previously 
described.33 Culture medium was changed every other day 
and differentiation induced at 39.5°C when cells reached 80% 
percentage of confluence. Routine culture methods and differ-
entiation media for mESCs containing β-glycerophosphate, 
ascorbic acid, and 1α 25(OH)
2
 vitamin D
3 
factors were used, 
as previously described.34 For both hFOB 1.19 and mESCs 
cell lines, 3,500 cells/cm2 were seeded onto CNT-sprayed 
coverslips, and differentiation was induced for 28 days.
Analysis of cellular morphology
Cells were fixed with 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for 1 hour at room temperature (RT). Cov-
erslips were washed three times in 0.1 M sodium cacodylate 
and RT-incubated in a solution containing 1% osmium tetrox-
ide in 0.1% sodium cacodylate. Coverslips were dehydrated 
in a graded ethanol series (30%, 50%, 70%, 90%, and 100%), 
and subjected to critical-point drying for 1 hour. Specimens 
were sputter-coated with gold palladium (SCD 040; Oerlikon 
Balzers Coating AG, Balzers, Liechtenstein) and imaged in a 
scanning electron microscope (SEM; Philips XL30, Philips/
FEI Corporation, Eindhoven, the Netherlands) at an accel-
erating voltage of 10 kV. All SEM reagents were purchased 
from Electron Microscopy Sciences (Hatfield, PA, USA).
cytotoxicity assays
Cytotoxic influence of in-suspension SWCNTs was deter-
mined by XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2-
H-tetrazolium-5-carboxanilide) assay (XTT cell proliferation 
assay kit; ATCC) following the manufacturer’s instructions. 
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Briefly, 4×103 cells/well were seeded into 96-well tissue 
plates and incubated for 24 hours with SWCNT suspen-
sions at the following concentrations: 1, 5, 10, 20, 25, 50, 
75, and 100 μg/mL. Potential release of sprayed SWCNTs 
from coverslips into the media was assayed for 34 days. 
Measurements were performed at 490 nm (λ) in a micro-plate 
absorbance reader (iMark; Bio-Rad Laboratories, Hercules, 
CA, USA).
Biochemical and immunostaining assays
Quantitation of mineralized ECM from hFOBs and mESCs 
was performed at day 14, and again at day 28 upon differen-
tiation induction. Briefly, cells were fixed in 100% ethanol 
for 15 minutes and subsequently stained for 1 hour in 0.2% 
alizarin red solution (pH 6.4) at RT. Cells were then washed 
in an ascending ethanol series to remove unspecific signals. 
Bound alizarin red was extracted using 20% methanol and 
10% acetic acid in water. After 15 minutes, the methanolic 
mixture was transferred to a 96-well plate and quantified at 
450 nm. Resulting values were normalized to the protein 
content (bicinchoninic acid protein assay; Thermo Fisher 
Scientific, Waltham, MA, USA).
Ocn protein secreted to ECM was detected by immuno-
fluorescence. Cells were fixed in ice-cold methanol/acetone 
(7:3) for 15 minutes at -20°C. Subsequently, a blocking 
step was performed with 10% fetal bovine serum and 0.5% 
bovine serum albumin in 1× phosphate buffered saline 
(PBS) for 30 minutes at 37°C prior to incubation with an 
anti-osteocalcin rabbit polyclonal antibody (EMD Millipore, 
Billerica, MA, USA). After washing in 1× PBS, samples 
were incubated with Alexa Fluor® 488 donkey anti-rabbit 
immunoglobulin G (Thermo Fisher Scientific, Waltham, 
MA, USA) secondary antibody in the presence of 4′, 6-di-
amidino-2-phenylindole (Millipore) to counterstain nuclei. 
Secondary antibody was visualized with a fluorescence 
microscope (Eclipse Ti; Nikon Instruments, Melville, NY, 
USA). A similar procedure was followed to immune detect 
osteopontin (Opn) protein.
gene expression analysis
Total RNA isolation from cells (RNAqueous®-4PCR Kit; 
Thermo Fisher Scientific) and from the ribcage of 4-week-old 
rats (RNeasy® Plus Mini Kit; Qiagen NV, Venlo, the 
Netherlands) was conducted according to manufacturers’ 
instructions. Total RNA isolation from cartilage fractions was 
performed as described by Mallein-Gerin and Gouttenoire.35 
In all cases, cyclic deoxyribonucleic acid (cDNA) was 
synthesized with an iScript™ cDNA Synthesis Kit (BioRad 
Laboratories). Primers used are listed in Table S1. Real-
time quantitative polymerase chain reaction (RT-PCR) was 
performed in an ABI 7900HT instrument using Fast SYBR® 
Green Master Mix (Thermo Fisher Scientific). Expression 
fold values are shown as 2(-ΔΔCt), which are relative to con-
trol conditions and normalized to endogenous control gene 
expression. RT-PCR products corresponding to pluripotent 
genes were visualized on 2% Tris-Borate-EDTA (ethylene-
diaminetetraacetic acid) agarose gels. 
Rat implant preparation and surgery
Thin human femur cortical bone strips, of 10–12 mm in 
length and 4–5 mm in width, were microperforated with a 
350°μ diameter drill, creating 20 perforations/cm2. Lipid was 
then extracted with 95% ethanol and diethyl ether. Demin-
eralization and sterilization were conducted as described by 
Gendler.36 After aeration, bone allografts were freeze-dried 
for 5 days and then packaged into double plastic pouches. 
One-half of bone implants were treated with SWCNTs, 
while the other half was not. CNT treatment consisted of 
placing the implants into 1 g/L COOH–SWCNT solution 
for 12 hours at 20°C, followed by several washes with run-
ning deionized sterile water for 12 hours at 20°C. Before 
implantation, allografts were reconstituted in physiologic 
PBS for 30 minutes. Cartilage preparations were excised 
from cadaver donors under aseptic conditions, as previously 
described.37,38 Briefly, cartilaginous sections were washed, 
frozen in liquid nitrogen vapor, and then transferred to a 
freeze-drying chamber with the external condenser set at 
60°C and the sheaf between 20°C–30°C (VirTis Bench Top 
Pro Freeze Dryer, SP Scientific, Warminster, PA, USA). 
Cartilage sections were freeze-dried to a residual moisture 
content of 3%–6%, and subsequently ground in a turbo 
grinding mill (PALLMANN Maschinenfabrik GmBH & 
Co. KG, Zweibrücken, Germany) into particles 200–300 μm 
in size.
Table 1 Technical characteristics of carbon nanotubes
Carbon nanotubes Length Diameter Purity Chemical functionalization Fabrication method
COOH–SWCNTs 1–5 μm 1.5 nm 95% cOOh– cVD
COOH–MWCNTs 5–20 μm 25 nm 95% cOOh– cVD
Abbreviations: CNTs, carbon nanotubes; COOH–SWCNTS, carboxyl-modified single-walled nanotubes; COOH–MWCNTs, carboxyl-modified multi-walled nanotubes, 
cVD, chemical vapor deposition.
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All animal studies were conducted in accordance 
with the principles and procedures outlined by the 
University of California Guidelines for Animal Research. 
Isoflurane-vapor-anesthetized, 6-week-old nude rats (Crl:NIH-
Foxn1rnu) were used for implant surgery. Implant incision and 
preparation was conducted as previously described.39 Incisions 
of 1 cm were made parallel to the most caudal rib, and a 1.5 cm 
cavity prepared for implant placement by inserting a blunt 
probe rostrally under the skin to create a chamber overlying the 
lateral rib cage. For each rat, untreated implants were inserted 
into the cavity on the right side of the animal, and SWCNT-
treated implants inserted on the left. Incisions were carefully 
closed with skin staples, and the animals returned to their cages 
for recovery. No systemic effects caused by SWCNTs from 
treated implants were observed on control implants.
Histological analysis
After 4 weeks, excised allografts were fixed in neutral buff-
ered formalin (Sigma-Aldrich) and post-fixed in Bouin’s 
fluid (Sigma-Aldrich) after washing for 24 hours in 1× PBS. 
Specimens were then dehydrated in graded ethanol, cleared 
in xylene, embedded flat in paraffin, and sectioned along their 
longitudinal axis at 10 μm. Sections were collected on acid-
cleaned glass slides, dried at 40°C overnight, and stained with 
hematoxylin and eosin. After staining, sections were dehy-
drated, cover-slipped with DPX Mountant (Sigma-Aldrich 
Co., St Louis, MO, USA) and digitally imaged with a cooled 
charge-coupled device camera mounted on an Olympus 
DMRXA microscope (Olympus Corporation, Tokyo, Japan). 
Images collected at the same magnification were cropped 
and assembled into composites with Adobe Photoshop CS4 
Software (Adobe Systems Inc., San Jose, CA, USA).
statistical analysis
All data are expressed as mean ± standard deviation of mean 
of at least three independent experiments. For statistical 
analysis, one-way analysis of variance (ANOVA) test was 
used and a value of P0.05 was considered statistically 
significant.
Results
Effect of SWCNT scaffolds 
on cell morphology 
To investigate whether CNT-induced nanoroughness might 
cause putative changes on cell number and morphology, both 
hFOB and mESC cell lines were cultured on COOH–SW-
CNT- and COOH–MWCNT-sprayed coverslips for 3 days. 
SEM revealed typical cell diameters of ~40 μm in hFOB 
cells, with flat, growing cell bodies (Figure 1A–C). Higher 
magnification revealed the presence of nanometer-scale 
cytoplasmic prolongations (Figure 1E and F) for these cells 
on both types of CNT scaffolds, while prolongations were 
less abundant – or practically absent – on control coverslips 
(Figure 1D). Nanosized prolongations were more abundant 
on MWCNTs (Figure 1F), suggesting that cells attempted 
to adhere to this type of substrate (denoted by white arrows 
in Figure 1F). While hFOBs showed a reduction in number 
when grown on MWCNTs (Figure 1C), mESCs showed typi-
cal colony morphology on control (Figure 1G and H) and on 
SWCNT (Figure 1J and K) coverslips. The number of hFOB 
and mESC colonies was compared, and similar results were 
noted for controls (Figure 1G) and SWCNTs (Figure 1H). 
However, similar to other results described in this section, 
a reduction in mECS colony number plus an abnormally round 
morphology was observed on COOH–MWCNTs ( Figure 1I), 
confirming our previous suspicions that an increase in the 
dimension of our tested scaffolds represented an impairment 
of these cell lines’ adhesion. In addition, higher magnification 
revealed the presence of nano-prolongations on scaffolds, 
which allow adhesion of colonies to COOH–SWCNTs 
( Figure 1K); in contrast, nano-prolongations were absent 
from controls (Figure 1J). This data confirmed the notion that 
a dimensional increase in scaffold geometry from single- to 
multi-walled structures impaired cellular adhesion, and that 
this impairment is independent of the cell line tested. There-
fore, further investigation on COOH–MWCNT substrates 
was not included in this work. 
Impact of SWCNTs on cell viability
To determine possible cytotoxic effects of SWCNTs in 
suspension on the proliferative properties of both progeni-
tors, XTT assays were conducted. SWCNT concentrations 
ranged from 1–100 μg/mL. Our assays revealed that COOH–
SWCNT concentrations 20 μg/mL elicited cytotoxicity 
(P0.01) in both cell lines, causing a decrease to 47% and 
22% viable cells for hFOB and mESC lines, respectively 
(Figure 2A and B). Based on these results, we then deter-
mined whether the highest noncytotoxic concentration would 
affect cell proliferation long-term. Cells cultured for up to 
72 hours did not show any overt negative effects on their 
proliferative properties (Figure 2C). 
Finally, release of SWCNTs from coverslips into the 
medium was analyzed for a period of 34 days (Figure 2D) 
by collecting the liquid phase every 2 days, as described in 
the “Methods” section. Maximum SWCNT concentration 
peaks of ~2.5–3 μg/mL were found at 18, 30, and 34 days 
(Figure 2D). These concentrations were about 10-fold lower 
than the cytotoxic concentration identified previously in this 
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section (Figure 2A and B). Minimal release of SWCNTs into 
the medium ensured the absence of cytotoxic effects, predi-
cated further experimentation, and validated the suitability 
of the chosen coating procedure.
Influence of SWCNT scaffolds 
on osteogenic differentiation 
To examine osteoinductive effects of SWCNTs on mESCs, 
we initially investigated whether SWCNTs could pro-
voke any change in mRNA abundance of the three master 
regulators of pluripotency, Oct3/4, Nanog, and Sox-2. By 
conventional and quantitative RT-PCR (Figure S1), mRNA 
abundance of these genes was measured from three different 
passages (P3, P6, and P9) of cells cultured on SWCNTs. 
Levels of all three mRNAs remained unchanged compared 
to levels found for cells grown on control coverslips. From 
these quantitative data and from the absence of morpho-
logical changes in mESC colonies, it may be inferred that 
CNTs used in our current research do not alter the identity 
of undifferentiated ESCs. 
Control
A B C
D E F
G H I
J K L
COOH–SWCNTs COOH–MWCNTs
Figure 1 Scanning electron microscopy micrographs of hFOB (A–F) and mesc (G–L) cell lines after 3 days of culture on control and carboxyl-modified CNTs.
Notes: hFOB cells growing on control, COOH–SWCNT, and COOH–MWCNT substrates (A, B, and C, respectively); establishment of cytoplasmic nanoprotrusions on control, 
COOH–SWCNT, and COOH–MWCNT scaffolds, as seen at higher magnification (D, E, and F, respectively); and mESC colonies adhering to control scaffolds, COOH–SWCNTs, 
and COOH–MWCNTs (G, H, and I, respectively). Inset (I) shows abnormal morphology of colonies grown on COOH–MWCNTs magnified; higher magnifications depict 
establishment of nanoprotrusions on control and COOH–SWCNT substrates (J and K, respectively); inferred increase in nanoroughness introduced by COOH–MWCNTs (L). 
White arrows in Figures 1E, F and K depict the establishment of cytoplasmic prolongations of the cells to adhere to the scaffold.
Abbreviations: hFOB, human fetal osteoblast; mesc, murine embryonic stem cell; cNTs, carbon nanotubes; COOH–SWCNTs, carboxyl-modified single-walled CNTs; 
COOH–MWCNTs, carboxyl-modified multi-walled CNTs.
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We also investigated the influence of SWCNTs on 
osteogenic differentiation potential of both mESC and hFOB 
progenitors (Figure 3A, panels a–f, respectively). For 
mESCs, a cell medium lacking leukemia inhibitor factor but 
with proper osteogenic factors added, was used. The earliest 
mineralization on SWCNT scaffolds was observed at day 7 
(Figure 3A, panel d), as evidenced by the presence of small, 
mineralized aggregates (indicated by white arrows), which 
were absent on control coverslips (Figure 3A, panel a). 
Differences in mineralization became more evident at days 
14 and 28, as larger mineralized aggregates were found on 
SWCNT coverslips (Figure 3A, panels e and f) as compared 
to controls (Figure 3A, panels b and c).
mRNA abundance of representative bone marker genes 
osterix (Osx), collagen type I (Col I), osteopontin (Opn), and 
osteocalcin (Ocn) was then assayed. The analysis revealed 
that expression levels of Osx and Opn genes were signifi-
cantly upregulated in mESCs differentiated on SWCNTs at 
all assessed time points (P0.05, Figure 3B). Specifically, 
Osx expression was upregulated 2.4-, 3.8-, and 3.4-fold on 
SWCNTs, followed by similar increases in Ocn expression at 
the two later time points, reflecting the function of Ocn as a 
marker of fully matured osteoblasts. In contrast, overall Col I 
expression did not show any statistical difference compared 
to controls, except on day 14 when it was slightly increased 
(to 1.7-fold) from cells differentiated on SWCNTs.
Similarly, mineralized nodules were absent on control 
coverslips (Figure 3C, panel b), but appeared as early as day 
14 in hFOBs cultured on SWCNTs (white arrows in Figure 3C, 
panel e). Toward the end of the experiment, the number and 
size of mineralized nodules was only slightly higher and the 
color only slightly darker on SWCNTs than on control cover-
slips (Figure 3C, panels c and f, respectively). We quantified 
the expression levels of bone-related genes using the same 
methodology (Figure 3D). Due to only minor microscopic 
differences observed in osteogenic yield, additional osteoblast 
genes were included in the assessment of bone specific gene 
expression: core binding factor alpha-1 (Cbfa-1), and alka-
line phosphatase (Alp), two early–intermediately expressed 
markers. The expression level of all genes was significantly 
elevated at all assessed time points, with the exception of Col 
I and Ocn, which were elevated from day 14 onward. Specifi-
cally, Cbfa-1, Osx, and Alp genes showed an early, steady 
state expression maintained at a similar level (2- to 2.5-fold 
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Figure 3 Induced osteogenic differentiation in mESC and hFOB cell lines cultured on COOH–SWCNTs. 
Notes: representative images taken at days 7, 14, and 28 of mESCs (A) and hFOBs (C) on control (panels a–c), and COOH–SWCNT (panels d–f) substrates. White arrows denote 
formation of early-mineralized nodules into ecM. scale bar =500 μm. Quantitative expression of bone-related markers shown in bar graphs (B, D, and F). results normalized to 
endogenous B-actin relative to controls. Dashed lines (B and D) indicate values of target genes in control conditions; *P0.01 vs respective control group. Immune-fluorescence 
images (E) depict presence of secreted Ocn (green color) in mESCs and hFOBs on control (panels a and e) and COOH–SWCNT (panels c and g) substrates. scale bar =500 μm. 
Counterstaining with DAPI (blue color) is shown in (E) (panels b, d, f, and h). Bar graph (F) shows normalized alizarin red quantitation from hFOBs and mescs on all substrates. 
*P0.01.
Abbreviations: mesc, murine embryonic stem cell; hFOB, human fetal osteoblast; COOH–SWCNTs, carboxyl-modified single-walled carbon nanotubes; ECM, extracellular 
matrix; mRNA, messenger RNA; vs, versus; Ocn, osteocalcin protein; DAPI, 4’,6-diamidino-2-phenylindole; Cbfa-1, core-binding alpha factor I; Osx, osterix; Col I, collagen type I; 
Alp, alkaline phosphatase; Opn, osteopontin; Ocn, osteocalcin.
over controls) across the 28-day window on SWCNTs. For 
Opn and Ocn, a steeper upregulation was found between the 
first and second week of differentiation, and their expression 
was maintained at all later time points at ~3.7- and 2.7-fold 
over controls, respectively. Taken together, our results 
revealed a positive influence of SWCNT scaffolds on osteo-
genic differentiation yield of hFOB and mESC progenitors. 
To further validate whether the presence of SWCNT 
scaffolds accelerates the formation of fully mature osteoblast 
cells, we evaluated the presence of secreted Ocn protein 
at day 28 of the osteogenic induction protocol. As seen 
in Figure 3E, results revealed a major abundance of Ocn, 
shown in green, when mESCs and hFOBs were differenti-
ated on SWCNTs (panels c and g, respectively) compared 
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to control differentiations (panels a and e), correlating with 
mRNA levels discussed previously in this section. Finally, 
alizarin red assays at days 14 and 28 confirmed a general 
increase in the deposition of mineralized matrix on SWCNTs. 
This deposition was more accelerated at the end of differ-
entiation (2-fold) than at mid-term evaluation (1.5-fold, day 
14) for mESCs. Similarly, mineralization from differentiated 
hFOBs revealed an increase of up to 2.75- and 1.8-fold at days 
14 and 28 compared to mineralization on control scaffolds. 
ectopic bone formation after DBM 
and SWCNT-treated cartilage 
allograft implantation 
In an attempt to translate in vitro results into in vivo 
application of CNTs, 6-week-old nude rats were subjected 
to implantation with human DBM and cartilage particle 
allografts, which had been soaked in SWCNTs. Implants 
were subcutaneously placed into pouches in the pectoralis 
muscle, and subsequent ectopic bone formation observed. 
To provide an overview of implantation methodology, 
selected areas and number of perforations made are shown 
in Figures S2 and S3. Four weeks post-implantation, 
implant containing both SWCNTs and DBM (indicated as 
“NT” in Figures 4 and 5) were well populated by host cells 
and vascular channels, indicating the high permeability and 
pore interconnectivity of these scaffolds (Figure 4C–E, 
and at higher magnification in Figure 4F). In both control 
and treated implants, interiors of microperforations were 
ingrown with a large number of vascular channels, and with 
host cells of different morphology ranging from loosely 
packed connective tissue cells to densely packed, mesen-
chymal cells, or differentiated active osteoblasts and encased 
osteocytes (Figure 4A and B and Figure 4C–G for control 
and SWCNT implants, respectively). The secretory activity 
of surrounding osteoblasts depositing new bone matrix and 
thereby eroding the microperforations’ outlines, was also a 
common phenomenon in both instances, while the recruitment 
of densely packed mesenchymal cells was greater surrounding 
SWCNT grafts (Figure 4C and E) than in controls (Figure 4A 
and B). In addition, cartilaginous areas were highly abundant 
close to SWCNT/DBM implants, indicating the presence of 
new endochondral ossification centers (Figure 4D).
A C E
FDB
Figure 4 Histological sections of DBM with or without COOH–SWCNT scaffolds 4 weeks post-implantation on rat pectoris muscle.
Notes: Images from untreated control implants: DBM with COOH–SWCNT scaffolds (A); DBM without COOH–SWCNT scaffolds (B). Images from treated DBM plus 
COOH–SWCNT-treated implants at 10× magnification (C–E); inset in (D) at 40× magnification (F). acronyms and white arrows indicate presence of relevant events. 
Abbreviations: DBM, demineralized bone matrix; COOH–SWCNT, carboxyl-modified single-walled carbon nanotube; OB, osteoblasts; OC, osteocytes; V, vascular 
channels; NT, nanotubes; HL, Howship’s lacunae; CA, cartilage; CT, connective tissue; MC, mesenchymal cells.
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ectopic bone formation upon implantation 
of SWCNT-treated cartilage allografts 
Human cartilage preparations combined with SWCNTs were 
also implanted into the pectoralis muscle of nude rats, using 
the same methodology described in the previous section. 
Low magnification images show an overview of how and 
where cartilage-SWCNT implants were placed (Figure S4). 
Four weeks post-implantation, high compatibility of grafts 
with host tissue, absence of relevant inflammatory signals, 
recruitment of mesenchymal progenitor cells, and the pres-
ence of aligned osteoblasts were observed (Figure 5A–D). 
High osteoblast activity was also evidenced by the presence 
of ossification events on cartilage particles, especially clear in 
Figure 5A, in all selected areas. However, remarkable differ-
ences were found, such as large amounts of connective tissue, 
Howship’s lacunae which identify multinucleated osteoclasts 
(Figure 5A and B), and the presence of few osteocytes. This 
suggested an early–intermediate ossification stage compared 
to the more advanced ossification in DBM implants.
To compare the effectiveness of both transplants quanti-
tatively, mRNA levels of bone-specific genes were used as a 
measure for osteoinductivity (Figure 6B). Increased expres-
sion of Cbfa-1, Col I, Opn, and Ocn genes (5.6-, 4.1-, 5.3-, 
and 4.4-fold, respectively) was found in cartilage/SWCNT 
implants compared to untreated groups. Similar behavior 
was observed in the case of DBM/SWCNT implants, where 
the expression of Cbfa-1, Opn, and Ocn was 6.0-, 9.5-, and 
6.9-fold higher than in the control, while Col I expression 
was downregulated. These data confirmed the notion that 
the tissue was more mature in CNT-treated transplants. In 
addition, the upregulation observed for Opn markers, an 
early–intermediate indicator of bone formation, correlated 
with the highest abundance of its encoded protein in both 
treated specimens (Figure 6A, panels c and g for DBM- and 
cartilage-treated implants, respectively). 
Discussion
Nanotechnology has allowed the possibility of manufacturing 
materials, such as CNTs, that can be utilized in distinct bio-
logic fields. Although CNTs have been studied extensively, 
their applications are still controversial due to the appear-
ance of cytotoxic effects, especially when they are used in 
suspension.12–15 The main hypothesis for this study was that 
SWCNTs are ideal scaffolds to promote bone formation 
due to the similar geometry they share with collagen fibrils, 
a major component of osteoblasts’ ECM. This capability 
was assayed with two unspecialized cell lines, and further 
elucidated in vivo by using a nude rat model. hFOBs were 
selected as a cellular model for this study, because they prolif-
erate more quickly and are more homogeneous than primary 
cultured bone cells. In addition, they differentiate upon alter-
ing the culture temperature from 33.5°C to 39.5°C, without 
adding any osteogenic factor.34,40–42 Advantages of employ-
ing the second in vitro cell line, murine ESCs, lie in their 
A C
DB
Figure 5 Histology sections of cartilage granules soaked with COOH–SWCNT scaffolds 4 weeks post-implantation on rat pectoris muscle.
Notes: sections (A–D) at 10× magnification. All the parts of this Figure are the result of the implantation of human cartilage particles soaked with COOH-SWCNTs. Each 
part was selected from different areas of the tissue that reveal distinct stages of the osteogenic process. Acronyms and black arrows indicate relevant events. 
Abbreviations: COOH–SWCNT, carboxyl-modified single-walled carbon nanotube; OB, osteoblasts; V, vascular channels; NT, nanotubes; HL, Howship’s lacunae; CA, 
cartilage; CT, connective tissue; MC, mesenchymal cells.
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hence proliferation. Although this observation differs from 
previous reports,28,29 it was in line with our previous research 
on osteosarcoma rat cells,17 and could explain why SEM 
analysis – which indirectly revealed distinct levels of adhe-
sion of these progenitors for the selected substrates – failed 
for similar types of MWCNT scaffolds constructed by other 
research groups.19 Although we did not further investigate 
this matter, our observations may be the basis for further 
exploration into the study of the molecules mediating this 
difference in cell adhesion.
Second, in trying to shed light on the controversial 
application of CNTs for future biomedical purposes, we 
analyzed whether COOH–SWCNTs in suspension might 
have a cytotoxic effect. Our XTT experiments revealed a 
toxic effect on cell proliferation when SWCNT concentra-
tions were 20 μg/mL. Clearly, our results are positioned 
between those that did not describe toxic effects of CNTs 
in suspension,19 and those that contraindicate their use15 by 
providing a threshold concentration for toxicity. Furthermore, 
we evaluated the release of sprayed SWCNTs into the culture 
medium, a single key to the validation of the coverslip coat-
ing procedure, and results revealed the absence of significant 
leaking during the entire culture time. 
Before assaying the impact of SWCNT scaffolds on the 
osteogenic differentiation of mESCs, we determined the 
expression profile of canonical stemness genes. Although 
neither teratoma formation assays nor protein levels of 
pluripotent markers were investigated, the expression pro-
files of Oct3/4, Sox-2, and Nanog genes were maintained in 
mESCs cultured on control and SWCNT coverslips for up 
to a period of nine cell passages. In a second step, induction 
of osteogenesis of mESC and hFOB cells was analyzed. The 
three major phases occurring in osteogenesis have been well 
established in the past,44 and display a temporally and sequen-
tially organized expression pattern of typical markers. Thus, 
osteogenic differentiation is controlled by specific transcrip-
tion factors such as Cbfa-1 and Osx. Osx is a transcription 
factor acting downstream of Cbfa-1, and is implied in the 
regulation of genes such as Opn, Ocn, and Col I; it also par-
ticipates by translating mechanical stimuli into a coordinated 
cellular response to Cbfa-1.49–51 In general, we observed an 
upregulation of these markers that was sharper for Osx at 
early time points, suggesting that the expression of remaining 
genes might rely on this master regulator. In turn, it is known 
that ECM mineralization depends on the expression of Opn 
and Alp genes.52 These two genes were equally upregulated 
in our experimental conditions. As such, Opn, with encoded 
product connecting ECM organic and inorganic phases,52 
was upregulated at assayed time points. Very surprisingly, 
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Figure 6 Immune detection of secreted Opn protein and bone marker expression 
analysis performed on implants 4 weeks post-implantation.
Notes: The presence of Opn (A) in DBM (panels a–d) and cartilage implants (panels 
e–h); control DBM and cartilage implants (panels a and e, respectively); Opn in treated 
DBM and cartilage implants (panels c and g, respectively); counterstaining with DAPI 
(panels b, d, f, and h); scale bar =500 μm. ectopic bone formation (B) as measured 
by mRNA abundance. Results are normalized to endogenous gene Gapdh and are 
relative to the expression of the tested genes from untreated control implants. Full 
grey and black bars represent data obtained from Cartilage and DBM treated implants; 
*represents significant values relative to control type of implants. *P0.01.
Abbreviations: DBM, demineralized bone matrix; Opn, osteopontin protein; DaPI, 
4′,6-diamidino-2-phenylindole; cartilage-CNT, cartilage particles soaked in a COOH–
SWCNT suspension; DBM-CNT, demineralized bone matrix particles soaked in a 
COOH–SWCNT suspension; mRNA, messenger ribonucleic acid; Cbfa-1, core-
binding alpha factor I; Col I, collagen type I; Opn, osteopontin; Ocn, osteocalcin; Gapdh, 
glyceraldehyde-3-phosphate dehydrogenase; vs, versus; COOH–SWCNT, carboxyl-
modified single-walled carbon nanotube.
pluripotent nature,43 hence their capability to differentiate 
into bone cells,44,45 and in their prior extensive use in the 
toxicity screening of chemical compounds;44–48 they therefore 
represent a good model to test CNT-induced toxicity.
To identify whether CNT-based scaffolds induce changes 
in cellular morphology and cell or colony number of these 
progenitors, hFOBs and mESCs were subjected to SEM 
analysis. Three common conclusions were inferred from this 
analysis: 1) SWCNT modification of the substrate caused 
nanoscale cytoplasmic protrusions that ensured proper cel-
lular adhesion; 2) SWCNTs did not induce any morphological 
changes; but 3) MWCNTs induced morphological changes 
or reduction in cell numbers. The larger dimensions of the 
MWCNT fibrils thus seemed to impair cell adhesion, and 
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we did not find any significant differences in Col I expres-
sion during mESC differentiation. This led us to speculate 
that the presence of CNTs on the coverslips, which mimic 
collagen fibrils, avoids unnecessary production of collagens. 
Last, Ocn, a marker of fully differentiated osteoblasts, was 
upregulated in both cell lines, correlating with the higher 
abundance of its protein at the end of differentiation. 
DBM and cartilage particles are commonly used implants 
in surgical procedures and dental reconstruction. We analyzed 
ectopic bone formation in nude rats implanted with human 
DBM and cartilage allografts soaked with COOH–SWCNTs. 
The selection of COOH covalently bound to the SWCNT core 
was based on the fact that COOH increases water solubility 
of CNTs, thus enhancing their biocompatibility.17 In addi-
tion, microperforated bone was used rather than particulate 
bone preparations to allow for a more precise morphometric 
measurement of osteogenesis.37 Untreated implants were 
placed on the right side of each animal, while SWCNT 
implants were positioned on the left of side, thus reduc-
ing putative inter-animal variations. Histological analysis 
revealed an interconnectivity of implanted biomaterials and 
the absence of local inflammatory responses, suggesting a 
high biocompatibility. Erosion of microperforation walls, 
neo-vessel formation and recruitment of progenitor cells 
surrounding the biomaterials were an evident phenomenon 
in all instances 4 weeks after implantation. A large number 
of immersed osteocytes in SWCNT/DBM perforations 
suggested a more advanced stage of induced osteogenesis 
compared to untreated DBM. In contrast, ossification events 
were delayed in cartilage-based implants, while multinucle-
ated osteoclasts were mainly observed in treated implants, 
revealing increased bone remodeling activity. Further analy-
sis of gene expression revealed similar trends to prior assays, 
although the expression of Cbfa-1, Opn, and Ocn expression 
was more acute compared to control implants, emphasizing 
the differences between our study models. 
Conclusion
The results of this study demonstrated the osteogenic prop-
erties of SWCNTs in three different models: two cellular 
models from distinct species, and a rodent animal model. 
Improved osteogenesis was observed using different 
approaches and was found to be accentuated depending on 
the precommitment of each cell line. In contrast, results from 
our in vivo model reinforce prior studies of CNTs described 
to date.16–19 After 4 weeks’ implantation, initial evidence of 
enhanced ectopic bone formation was found. Histological 
sections of human allografts combined with SWCNTs fur-
ther confirmed by transcriptional analysis of classical bone 
markers and increased presence of secreted Opn protein, 
clearly revealed the osteoinductive properties of CNTs. 
Taken together, these results reinforce prior research done 
with CNTs and constitute an opened window to continue 
with further investigations in other models.
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Table S1 Nucleotide primer sequences of target genes
Gene Accession no Primer sequences (5′–3′) Amplicon (bp) 
Homo sapiens
Osx NM_152860.1 F: ccTcTgcgggacTcaacaac 
r: agcccaTTagTgcTTgTaaagg
128
Cbfa1 NM_001015051 F: gcggTgcaaacTTTcTccag 
r: acTgcTTgcagccTTaaaTgac
116
Alp NM_000478.2 F: acTggTacTcagacaacgagaT 
r: acgTcaaTgTcccTgaTgTTaTg
 97
Opn NM_001040058 F: TcaccTgTgccaTaccagTTa 
r: ggccacagcaTcTgggTaTT
86
Ocn NM_199173.2 F: cTcacacTccTcgcccTaTTg 
r: gcTTggacacaaaggcTgcac
109
Col I NM_000088.3 F: TgTTcagcTTTgTggaccTc 
r: TTggTgggaTgTcTTcgTcT
111
B-Actin NM_001101.3 F: gagcacagagccTcgccTTT 
r: TcaTcaTccaTggTgagcTgg
70
Rattus norvegicus
Cbfa-1 NM_053304.1 F: agccacacgTgTagTaaaggcTca 
r: aTTccacTTccTgcaaagcTgcTg
170
Col I NM_013414.1 F: acTTcccTacccagcaccTTcaaa 
r: aTgTTTccagTcTgcTgTgacccT
198
Ocn  NM_053470 F: agaacagacaagTcccacacagca 
r: TaTTcaccaccTTacTgcccTccT
185
Opn  NM_012881.2 F: TgagTTTggcagcTcagaggagaa 
r: aTcaTcgTccaTgTggTcaTggcT
199
Gapdh  NM_130458.3 F: acaagaTggTgaaggTcggTgTga 
r: agcTTcccaTTcTcagccTTgacT
199
Mus musculus
Osx  NM_017008.4 F: TcccTggaTaTgacTcaTcccT 
r: ccaaggagTaggTgTgTTgcc
93
Col I NM_007743.2 F: agTcgaTggcTgcTccaaaa 
r: agcaccaccaaTgTccagag
118
Opn NM_001204201.1 F: ggcTgaaTTcTgagggacTaacTa 
r: aagcTTcTTcTccTcTgagcTg
125
Ocn NM_031368 F: cgcTaccTTggagcTTcagT 
r: aTagcTcgTcacaagcaggg
88
Oct3/4 NM_001252452 F: agaggaTcaccTTggggTaca 
r: cgaagcgacagaTggTggTc
96
Nanog NM_028016 F: cacagTTTgccTagTTcTgagg 
r: gcaagaaTagTTcTcgggaTgaa
87
Sox-2 NM_011443 F: cggcacagaTgcaaccgaT 
r: ccgTTcaTgTaggTcTgcg
85
B-Actin NM_007393.3 F: gcTccggcaTgTgcaaag 
r: ccaTcacacccTggTgccTa
96
Abbreviations: Alp, alkaline phosphatase; Cbfa-1, Core-binding factor alpha1; Col I, Collagen type I; Ocn, Osteocalcin; Opn, Osteopontin; Osx, Osteorix; Nanog, Nanog 
homeobox; Oct3/4, Octamer-binding transcription factor 4; Sox-2, SRY-box containing gene 2; B-Actin, Beta-actin; Gapdh, Glyceraldehyde-3-phosphate dehydrogenase.
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Figure S1 Analysis of mRNA abundance of pluripotent genes from mESCs cultured on COOH-SWCNTs.
Notes: Left panel, representative agarose gel depicting the PCR products obtained from real-time-PCR analysis of Nanog, Oct 3/4, Sox-2 pluripotency-associated genes and 
endogenous control gene B-Actin. Total RNA fractions were isolated and cDNA synthesized from cells cultured at passages (P) 3, 6 and 9. Right panel; histogram from real-
time PCR analysis measuring the mRNA expression levels from the above pluripotency-associated genes. Results were normalized to endogenous B-Actin and relative to cells 
grown on glass control substrate. Bar graphs depict the means and standard deviations resulting from the analysis of gene expression from three independent experiments 
at the passages indicated.
Abbreviations: Oct3/4, Octamer-binding transcription factor 3/4; Nanog, Homeobox protein Nanog; Sox-2, Sex determining region Y-box 2; B-Actin, Beta actin; P3, P6 and P6, cell 
passages number 3, 6 and 9, respectively; COOH–SWCNT, carboxyl-modified single-walled carbon nanotube; mESC, murine embryonic stem cell; PCR, polymerase chain 
reaction.
Figure S2 Composition of haematoxylin-eosin images depicting three perforations of human DBM on rat pectoris muscle.
Notes: Perforations delimited by squared boxes were selected as representative control images in Figure 4 (referred as 4A and 4B). Overlapping of single images (magnification 
2.5×) was performed using the Adobe Photoshop CS4 software package.
Abbreviation: DBM, demineralized bone matrix.
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Figure S3 Composition of haematoxylin-eosin images depicting fourteen 
perforations of human DBM soaked in COOH-SWCNTs, on rat pectoris muscle.
Notes: Two out of these fourteen perforations were selected as representative 
images for DBM/COOH-CNTs implantation in Figure 4 (delimited by squared 
boxes and referred as 4C and 4D). Out of the perforations region, an area enriched 
by mesenchymal progenitors was also selected and included in Figure 4 (referred 
as 4E). Equally done than in Figure S2 overlapping of single images (magnification 
2.5×) was performed using the Adobe Photoshop CS4 package.
Abbreviations: COOH–SWCNT, carboxyl-modified single-walled carbon nano-
tube; DBM, demineralized bone matrix.
Figure S4 Composition of overlapping haematoxylin-eosin images corresponding 
to the transplantation of human cartilage particles soaked in COOH-SWCNTs on 
rat pectoris muscle.
Notes: In the composition cartilage particles perforations (referred by CA acronym) 
and their ossification (densely pink stained areas) can be noticed. Four areas, 
delimited by black line squared boxes, were selected as representative images of 
cartilage implants soaked with COOH-SWCNTs in Figure 5 (referred as 5A to 5D). 
Overlapping of singles images (magnification 2.5×) was performed using the Adobe 
Photoshop CS4 package.
Abbreviations: COOH–SWCNT, carboxyl-modified single-walled carbon nano-
tube; cOOh-cNT, .
